Literature DB >> 34392420

What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection?

Naoya Sato1, Shigeru Marubashi2.   

Abstract

The optimal type of hepatectomy for hepatocellular carcinoma (HCC)-anatomical or non-anatomical resection-remains controversial despite numerous comparative studies. There are common fundamental issues in published studies comparing anatomical resection with non-anatomical resection: (1) confounding by indication, (2) setting primary outcomes, and (3) a lack of a clear definition of non-anatomical resection. This degrades the quality of the comparison of the two types of surgery. To measure the therapeutic effect of hepatectomy, it is essential to understand the accumulated knowledge underlying these issues, such as the mechanism of hepatocellular carcinoma spread, tumor blood flow drainage theory, and the three patterns of hepatocellular carcinoma recurrence: (1) local intrahepatic metastasis, (2) systemic metastasis, and (3) multicentric carcinogenesis recurrence. Based on evidence that the incidence of local intrahepatic metastasis was so low it was almost negligible, the therapeutic effect of anatomical resection on the oncological survival was determined to be similar to that of non-anatomical resection. Recent research progress demonstrating the clinical impact of subclinical dissemination of HCC after surgery may stimulate new debate on the optimal surgical treatment for HCC beyond the comparison of anatomical and non-anatomical resection.
© 2021. Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Anatomical resection; Comparison; Hepatocellular carcinoma; Recurrence mechanism

Mesh:

Year:  2021        PMID: 34392420     DOI: 10.1007/s00595-021-02352-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  84 in total

1.  Anatomical versus non-anatomical resection for hepatocellular carcinoma.

Authors:  S Marubashi; K Gotoh; H Akita; H Takahashi; Y Ito; M Yano; O Ishikawa; M Sakon
Journal:  Br J Surg       Date:  2015-04-02       Impact factor: 6.939

Review 2.  Pathologic characteristics of hepatocellular carcinoma.

Authors:  T Nakashima; M Kojiro
Journal:  Semin Liver Dis       Date:  1986-08       Impact factor: 6.115

3.  Impact of Liver Cirrhosis on Perioperative Outcomes Among Elderly Patients Undergoing Hepatectomy: the Effect of Minimally Invasive Surgery.

Authors:  Kota Sahara; Anghela Z Paredes; Diamantis I Tsilimigras; J Madison Hyer; Katiuscha Merath; Lu Wu; Rittal Mehta; Eliza W Beal; Susan White; Itaru Endo; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-02-04       Impact factor: 3.452

4.  Safety of hepatectomy for elderly patients with hepatocellular carcinoma.

Authors:  Koichi Oishi; Toshiyuki Itamoto; Toshihiko Kohashi; Yasuhiro Matsugu; Hideki Nakahara; Mikiya Kitamoto
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

5.  Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey.

Authors:  Susumu Eguchi; Takashi Kanematsu; Shigeki Arii; Masatoshi Okazaki; Kiwamu Okita; Masao Omata; Iwao Ikai; Masatoshi Kudo; Masamichi Kojiro; Masatoshi Makuuchi; Morito Monden; Yutaka Matsuyama; Yasuni Nakanuma; Kenichi Takayasu
Journal:  Surgery       Date:  2008-04       Impact factor: 3.982

6.  Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma.

Authors:  Masaki Kaibori; Masanori Kon; Tomoki Kitawaki; Takayuki Kawaura; Kiyoshi Hasegawa; Norihiro Kokudo; Shunichi Ariizumi; Toru Beppu; Hiroyuki Ishizu; Shoji Kubo; Toshiya Kamiyama; Hiroyuki Takamura; Tsuyoshi Kobayashi; Dong-Sik Kim; Hee Jung Wang; Jong Man Kim; Dai Hoon Han; Sang-Jae Park; Koo Jeong Kang; Shin Hwang; Younghoon Roh; Young Kyung You; Jae-Won Joh; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2017-10-19       Impact factor: 7.027

Review 7.  A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma.

Authors:  Mashaal Dhir; Alyson A Melin; Jeffrey Douaiher; Chi Lin; Weining Ken Zhen; Shahid M Hussain; Jean-Francois H Geschwind; Maria B Majella Doyle; Ghassan K Abou-Alfa; Chandrakanth Are
Journal:  Ann Surg       Date:  2016-06       Impact factor: 12.969

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

Review 10.  A global view of hepatocellular carcinoma: trends, risk, prevention and management.

Authors:  Ju Dong Yang; Pierre Hainaut; Gregory J Gores; Amina Amadou; Amelie Plymoth; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08-22       Impact factor: 73.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.